Home

Vivo Ventures Fund VII, L.P.

CIK 1509160 · last filed 2022-07-01

Vivo Ventures Fund VII, L.P. is a corporate insider who has filed 7 SEC Form 4 insider transactions across 4 companies since 2013. The most recent filing shows the insider disposed of $1.28B of SRRA on Jul 1, 2022. Across all open-market trades the lifetime net is +$8.3M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $22.0M across reported positions. The firm reports its address in Palo Alto, CA. 25 SEC filings were submitted jointly with VIVO VENTURES VII, LLC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$22.00M

Companies

4

Total Filings

7

Lifetime Open-Market Net

$8.29M

Filer Profile

Reported Address
505 HAMILTON AVENUE, SUITE 200
PALO ALTO, CA 94301
Phone
(650) 688-0818
Related Filers
VIVO VENTURES VII, LLC — 25 joint filings, latest 2022-07-01
Vivo Ventures VII Affiliates Fund, L.P. — 25 joint filings, latest 2022-07-01
Vivo Capital Fund IX, L.P. — 5 joint filings, latest 2022-07-01
Vivo Capital IX, LLC — 5 joint filings, latest 2022-07-01
Vivo Opportunity, LLC — 5 joint filings, latest 2022-07-01
Vivo Opportunity Fund, L.P. — 4 joint filings, latest 2022-01-31
Vivo Opportunity Fund Holdings, L.P. — 1 joint filings, latest 2022-07-01
Vivo Capital Fund VIII, L.P. — same reported address
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Sierra Oncology, Inc. (SRRA) Delisted Director 0 $54.99 $0 $0 3 2022-07-01
CDXS 10%+ Owner 118,240 $1.47 $173.2K -$1.01M 1 2016-08-05
ACRS 10%+ Owner 4,101,997 $5.32 $21.82M $15.00M 1 2015-10-13
Lite Strategy, Inc. (MEIP) Delisted 10%+ Owner 198,988 $3.20 $636.8K -$5.70M 2 2013-07-02

Recent Filings

7 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2022-07-01 Sierra Oncology, Inc. (SRRA) Delisted Disp (D) −23,306,584 -$1.28B EDGAR
2022-01-28 Sierra Oncology, Inc. (SRRA) Delisted Exer (X) +4,287,059 $56.59M EDGAR
2020-01-31 Sierra Oncology, Inc. (SRRA) Delisted Conv (C) +12,992,826 $0 EDGAR
2016-08-05 CDXS Sell (S) −240,000 -$1.01M EDGAR
2015-10-13 ACRS Mixed +11,664,573 $15.00M EDGAR
2013-07-02 Lite Strategy, Inc. (MEIP) Delisted Sell (S) −22,011 -$166.8K EDGAR
2013-06-13 Lite Strategy, Inc. (MEIP) Delisted Sell (S) −708,819 -$5.53M EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.